![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Sagentia Grp | LSE:SGA | London | Ordinary Share | CH0012324965 | CHF0.10 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number:5400S Sagentia Group AG 17 April 2008 Sagentia Group AG ("Sagentia") Notification of Document Availability Copies of each of the following documents have today been submitted to the UK Listing Authority, and will be available for inspection at the UK Listing Authority's Document Viewing Facility, which is situated at: Financial Services Authority 25 The North Colonnade Canary Wharf London E14 5HS Tel: 020 7066 1000 The documents referred to are: - the Sagentia's consolidated annual accounts for the year ended 31 December 2007; - the Sagentia's consolidated annual accounts for the year ended 31 December 2006; and - the Sagentia's consolidated annual accounts for the year ended 31 December 2005. Enquiries: Sagentia Group AG Martin Frost (44) 1223 875200 www.sagentiagroup.com Hansard Group Andrew Tan (44) 207 2451100 www.hansardgroup.co.uk Arbuthnot Securities (44) 207 0122000 Antonio Bossi/ John Prior www.arbuthnot.co.uk Notes to editors: Sagentia Group AG Sagentia Group is a leading international technology consulting and venturing organisation, with a reputation for successfully commercialising emerging science and technology. The Group comprises two principal operating companies, Sagentia and Chord Capital. Sagentia is one of the world's pre-eminent technology management and product development companies. For 20 years the business has shown an unwavering commitment to innovation that has led to the launch of breakthrough products. Sagentia's facilities include state-of-the-art laboratories and are located in Europe in Cambridge, Frankfurt, and Stockholm; in Boston and Baltimore in the USA and in Hong Kong. The Group's venture management activities are managed through its FSA-regulated fund manager Chord Capital Limited. Through Chord Capital, venture and investee companies gain access to business building and corporate finance skills. Recent ventures and investments include CMR Fuel Cells plc and Nanoscience plc, listed on AIM, Sphere Medical Ltd and Atraverda Ltd. Sagentia Group is quoted on the LSE (SGA.L) This information is provided by RNS The company news service from the London Stock Exchange END DOCGUUWACUPRUBM
1 Year Sagentia Grp Chart |
1 Month Sagentia Grp Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions